Chloé Cloetens

Hunza is a venture capital investor focused on sectors including biotechnology, pharmaceuticals, medical technology and medical services. They also invest in high-tech industries such as software, energy, environmental technology, Internet and media. The firm targets companies with high-value creation potential and leverages their business experience, knowledge and networks to turn them into market leaders. They invest across development stages in seed, startup and expansion financing. Hunza invests globally through shareholder loans, majority or significant minority equity participations, mezzanine and bridge financing. Their investments have included traditional Chinese medicine, oncology, drug delivery technology and minimally-invasive medical devices for heart surgery.